blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2070928

EP2070928 - 7-azaindol-3-ylacrylamides active as kinase inhibitors [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.04.2015
Database last updated on 20.09.2024
Most recent event   Tooltip24.04.2015Application deemed to be withdrawnpublished on 27.05.2015  [2015/22]
Applicant(s)For all designated states
NERVIANO MEDICAL SCIENCES S.R.L.
Viale Pasteur, 10
20014 Nerviano (MI) / IT
[N/P]
Former [2009/25]For all designated states
NERVIANO MEDICAL SCIENCES S.r.l.
Viale Pasteur, 10
20014 Nerviano (MI) / IT
Inventor(s)01 / Casuscelli, Francesco
Via S. Michele del Carso, 1
20020 Dairago(MI) / IT
02 / Mongelli, Nicola
Via Tertulliano, 38
20137 Milan / IT
03 / Amici, Raffaella
Via Eugenio Montale, 34
26845 Codogno (Lodi) / IT
04 / Traquandi, Gabriella
Via Cilea, 106
20151 Milan / IT
05 / Menichincheri, Maria
Via Felice Casati , 19
20124 Milan / IT
06 / Ermoli, Antonella
Via Garibaldi, 13
20090 Buccinasco (MI) / IT
 [2009/25]
Application number, filing date08171301.811.12.2008
[2009/25]
Priority number, dateEP2007012305012.12.2007         Original published format: EP 07123050
[2009/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2070928
Date:17.06.2009
Language:EN
[2009/25]
Search report(s)(Supplementary) European search report - dispatched on:EP21.04.2009
ClassificationIPC:C07D471/04, A61K31/437, A61P35/00
[2009/25]
CPC:
C07D471/04 (EP); A61P35/00 (EP)
Designated contracting statesDE,   FR,   GB,   IT [2010/08]
Former [2009/25]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Als Kinasehemmer wirkende 7-Azaindol-3-ylacrylamide[2009/25]
English:7-azaindol-3-ylacrylamides active as kinase inhibitors[2009/25]
French:7-azaindol-3-ylacrylamides actifs en tant qu'inhibiteurs de la kinase[2009/25]
Examination procedure02.12.2009Examination requested  [2010/02]
18.12.2009Loss of particular rights, legal effect: designated state(s)
25.01.2010Despatch of communication of loss of particular rights: designated state(s) AT, BE, BG, CH, CY, CZ, DK, EE, ES, FI, GR, HR, HU, IE, IS, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR
11.07.2014Communication of intention to grant the patent
22.11.2014Application deemed to be withdrawn, date of legal effect  [2015/22]
12.01.2015Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2015/22]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.07.2014
Fees paidRenewal fee
27.12.2010Renewal fee patent year 03
27.12.2011Renewal fee patent year 04
29.04.2013Renewal fee patent year 05
27.05.2014Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.12.201205   M06   Fee paid on   29.04.2013
31.12.201306   M06   Fee paid on   27.05.2014
31.12.201407   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO0198299  (PHARMACIA & UPJOHN SPA [IT], et al) [A] 1-7 * page 1, line 6 - line 11 * * Formula (I); page 4 *
 [A]  - CAPLUS, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (19891125), Database accession no. 1989:594716, URL: STN, XP002522942 [A] 1-5 * abstract *
    [ ] - Y. NISHIKAWA ET AL., "Acrylamide derivatives as antiallergic agents. III. Synthesis and structure-activity relationships of N-[4-(4-diphenylmethyl-1-piperazinyl)butyl]- and N-[4-(4-diphenylmethylene-1-piperidyl)butyl]-3-heteroarylacrylamides", CHEMICAL AND PHARMACEUTICAL BULLETIN, PHARMACEUTICAL SOCIETY OF JAPAN, TOKYO; JP, (1989), vol. 37, no. 3, ISSN 0009-2363, pages 684 - 687
by applicant   - CURRENT OPINION IN CHEMICAL BIOLOGY, (1999), vol. 3, pages 459 - 465
    - PROC. NATL. ACAD. SCI., (2001), vol. 98, pages 10983 - 10985
    - J. CELL. SCI., (2001), vol. 114, pages 2903 - 2910
    - CIRC. RES., (2000), vol. 86, pages 15 - 23
    - PROC. NATL. ACAD. SCI., (1992), vol. 89, pages 9267 - 9271
    - J. BIOL. CHEM., (1999), vol. 274, pages 9133 - 9136
    - CELL. SIGNAL., (2002), vol. 14, pages 381 - 395
    - MOL. CELL. BIOL., (1997), vol. 17, pages 1595 - 1606
    - SCIENCE, (1997), vol. 275, pages 628 - 630
    - GENEV. DEV., (1999), vol. 13, pages 2905 - 2927
    - CURRENT BIOLOGY, (2002), vol. 12, pages 1251 - 1255
    - J. BIOL. CHEM., (2003), vol. 278, pages 21615 - 21622
    - EUR. J. BIOCHEM., (1999), vol. 263, pages 605 - 611
    - CANCER RES., (1997), vol. 57, pages 2124 - 2129
    - NAT. CELL. BIOL., (1999), vol. 1, pages 500 - 506
    - J. BIOL. CHEM., (1999), vol. 274, pages 1865 - 1868
    - J. CLIN. INVEST., (1999), vol. 106, pages 493 - 499
    - NAT. MED., (2000), vol. 6, pages 1004 - 1010
    - PROC. NATL. ACAD. SCI, (1996), vol. 93, pages 3636 - 3641
    - INT. J. CANCER, (1995), vol. 64, pages 280 - 285
    - NATURE, (1999), vol. 401, pages 33 - 34
    - ONCOGENE, (2000), vol. 19, pages 2324 - 2330
    - NEUROSCI., (2000), vol. 20, pages 2875 - 2886
    - PROC. NATL. ACAD., (2001), vol. 98, pages 7200 - 7205
    - NATURE, (2001), vol. 411, pages 355 - 365
    - NAT. REV. CANCER, (2002), vol. 2, pages 489 - 501
    - ANNU. REV. BIOCHEM., (2002), vol. 71, pages 333 - 374
    - MOL. CELL BIOL., (1999), vol. 19, pages 5083 - 5095
    - EMBO J., (2002), vol. 21, pages 3171 - 3181
    - GENE, (1998), vol. 211, pages 133 - 140
    - EMBO J., (1999), vol. 18, pages 5703 - 5713
    - CANCER RES., (2004), vol. 64, pages 7110 - 7116
    - J. BIOL. CHEM, (2006), vol. 281, pages 10281 - 10290
    - NISHIKAWA, YOSHINORI ET AL., CHEM. PHARM. BULL., (1989), vol. 37, no. 3, pages 684 - 7
    - TETRAHEDRON ASYMMETRY, (1996), vol. 7, no. 7, pages 2145 - 2150
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.